| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.26B | +22.9% |
| Cost of Revenue | $1.36B | +21.6% |
| Gross Profit | $907.7M | +25.0% |
| R&D Expense | $12.9M | +8.4% |
| SG&A Expense | $553.6M | +20.6% |
| Operating Income | $175.6M | +25.9% |
| Interest Expense | $83.5M | +41.9% |
| Pre-tax Income | $87.1M | +101.6% |
| Income Tax | $45.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $61.3M | -61.0% |
| Accounts Receivable | $341.4M | +27.3% |
| Inventory | $732.4M | +30.3% |
| Current Assets | $1.21B | +5.8% |
| Total Assets | $3.85B | +22.4% |
| Current Liabilities | $359.8M | -5.7% |
| Long-term Debt | $1.83B | +42.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.3M | -121.1% |
| Capital Expenditures | $64.3M | +61.2% |
| Investing Cash Flow | -$626.7M | -97.4% |
| Financing Cash Flow | $556.9M | +103.8% |
| Free Cash Flow | -$92.6M | -198.3% |
| +145.6% |
| Net Income | $36.4M | -68.2% |
| EPS (Diluted) | -$0.10 | -113.7% |
| Total Liabilities |
| $2.49B |
| +33.8% |
| Stockholders' Equity | $1.14B | +2.3% |